title: Serum trace metal and ceruloplasmin variability in individuals treated for pulmonary tuberculosis.
abstract: METHODS
  Investigation of trace metal behaviour during the treatment of active pulmonary tuberculosis (PTB) patients residing in Romania.
  
  
  OBJECTIVE
  To assess, follow and identify serum iron (Fe), copper (Cu) and zinc (Zn) levels in patients diagnosed and treated for active PTB.
  
  
  METHODS
  Chemical and statistical analysis of various biochemical parameters in 47 subjects diagnosed with active PTB and 170 healthy Romanian residents.
  
  
  RESULTS
  Copper and ceruloplasmin levels were increased in patients with active PTB compared to the control group (P < 0.01), while  the serum Zn level was significantly lower than in healthy subjects (P < 0.01) or within the normal range. The present study shows that there is a significant correlation between serum Cu concentrations and ceruloplasmin.
  
  
  CONCLUSIONS
  This study provides preliminary evidence that  Zn and Fe redistribution is operating as a primary host defence mechanism to reduce the availability of metals for microbial metabolism during infection. The study also calls attention to the fact that anti-tuberculosis treatment is sufficient to enhance the concentration of the antioxidant  species (Cu and ceruloplasmin). The data obtained suggest that serum Cu, Zn and Cu/Zn levels may serve as indirect pointers in the diagnosis of a disease but they cannot be considered as specific markers for TB.
authors.affiliation: Pulmonary Disease Division, Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania.
authors.forename: R I
authors.initials: RI
authors.lastname: Cernat
authors.forename: T
authors.initials: T
authors.lastname: Mihaescu
authors.forename: M
authors.initials: M
authors.lastname: Vornicu
authors.forename: D
authors.initials: D
authors.lastname: Vione
authors.forename: R I
authors.initials: RI
authors.lastname: Olariu
authors.forename: C
authors.initials: C
authors.lastname: Arsene
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000378:metabolism*; D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use; D016022:Case-Control Studies; D002570:Ceruloplasmin / Q000378:metabolism*; D003300:Copper / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007501:Iron / Q000097:blood; D008297:Male; D008875:Middle Aged; D012383:Romania; D014131:Trace Elements / Q000097:blood*; D014397:Tuberculosis, Pulmonary / Q000097:blood* / Q000188:drug therapy; D055815:Young Adult; D015032:Zinc / Q000097:blood
chemical_list: D000975:Antioxidants; D000995:Antitubercular Agents; D014131:Trace Elements; D003300:Copper; D007501:Iron; D002570:Ceruloplasmin; D015032:Zinc